Alembic Pharma Q1 First Cut – Ebitda and Ebitda Margin below e | Motilal Oswal Research

Alembic Pharma Q1 First Cut – Ebitda and Ebitda Margin below estimates

·         Net profit Rs162cr (down 44% YoY) – Expectation Rs219c

·         Ebitda Margina 17.8% vs 30.4% (YoY) – expectation 25.4%

·         Ebitda Rs235.9cr (down 42.1% YoY) – expectation Rs309.7cr

·         Income Rs1326cr (down 1.1% YoY) – expectation Rs1219cr